Navigation Links
$450,000 sweetener in colon cancer battle
Date:4/24/2008

UK-based Association for International Cancer Research this week announced it will fund a Griffith University project led by Dr Joe Tiralongo to further develop a potential anti-cancer treatment that had shown promising results in lab tests.

The grant will enable the team to test a range of new 'designer' compounds on tumours in living cells.

Research leader Dr Joe Tiralongo of Griffith's Institute for Glycomics, Queensland said the compounds target a unique sugar, sialic acid, believed to give cancer cells their deadly ability to spread through the body.

"A significant number of studies have shown a consistent link between the amount of the sugar sialic acid on the surface of cancer cells, and the ability of that cancer to metastasise, or spread to other parts of the body," he said.

Sialic acid is found in cells throughout the body, giving, for example, saliva its characteristic stickiness, but it is abnormally expressed on cancer cells.

"It exists in much greater numbers on the surface of cancer cells. You could almost describe it as a 'glue' that helps cancer cells bond to other cells throughout the body," Dr Tiralongo said.

"We are working to tailor an 'inhibitor' that will block the mechanism that enables cancer cells to express this sugar on its surface."

"If progression can be slowed and the cancer contained to one part of the body, it becomes a lot easier to treat with surgery."

He said while colon cancer was the primary target, the team would also screen inhibitors against other aggressive cancers, including breast cancer and neuroblastoma.

"These cancers all over-express sialic acid, so in theory what works for one cancer could work for others.

Colon cancer is one of the most dangerous types of cancer and the second most common cause of death from cancer, with one in 18 Australian men and one in 26 women affected.

Australian National Health and Medical Research Council reports patients with a localized colon cancer have an 88 % chance of survival, however this drops to just seven per cent when the cancer has spread to other organs.

Association for International Cancer Research Scientific Co-ordinator Dr Mark Matfield said preventing tumours from spreading would be a new way of treating cancer by controlling it.

"It is the ability of cancer to spread around the body which makes it fatal," he said.

"It would not cure it but, in most cases it would make a cure unnecessary because a non-spreading tumour would not be a significant health problem."


'/>"/>

Contact: Jeannette Langan
j.langan@griffith.edu.au
61-755-528-654
Research Australia
Source:Eurekalert

Related medicine news :

1. Artificial sweeteners linked to weight gain
2. Study finds that competency in colonoscopy requires experience with 150 cases or more
3. USC study finds evidence of gender-related differences in development of colon cancer
4. New Drug Duo Helps Cut Colon Cancer Risk
5. New Drug Duo Helps Fight Colon Cancer
6. New Treatments Help Fight Liver, Colon Cancer
7. Colon cancer risk perception associated with screening behavior
8. Patient Navigators Boost Colon Screens in Urban Minorities
9. Apple pectin, apple juice extracts shown to have anticarcinogenic effects on colon
10. High-Risk Blacks Less Likely to Get Colonoscopies
11. Popular Colonoscopy Prep Solution May Pose Kidney Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... ... gather at Boston CEO 2017 on May 30th and 31st at The Four ... forum for leading executives in the life sciences, offering exclusive access to key ...
(Date:5/26/2017)... ... 26, 2017 , ... Amir Qureshi, MD is the first physician in Arkansas ... stimulation system. The Nuvectra™ Algovita SCS System has been FDA approved as a treatment ... in Arkansas to introduce the most powerful SCS system and the only stretchable lead ...
(Date:5/26/2017)... ... , ... A new analysis of community health data reveals that four out ... Midwest. With the average cost of healthcare rising and the U.S. senior population expected ... and affordability of where they live. An annual 2017 report looked at a variety ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... ever copper, antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. ... “We are thrilled to partner with Cupron® to provide customers with a game ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... After raising ... Antzy Top gadget will continue to be available at a discounted crowdfunding price on ... with stress wherever they are, I also wanted to bring a fidget toy to ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... it has earned a spot on Forbes, ... was ranked among 500 U.S. employers as well as ... and Services. The annual Forbes ... survey of over 30,000 employees across 25 industries. The ...
(Date:5/9/2017)... 9, 2017  Semler Scientific, Inc. (OTCQB: SMLR), ... to improve the clinical effectiveness and efficiency of ... first quarter ended March 31, 2017. ... customers to identify when preventive care options are ... like heart attacks or strokes occur," said ...
(Date:5/6/2017)... Texas , May 5, 2017   Provista , ... with more than 200,000 customers, today announced Jim Cunniff ... a wealth of executive and business experience to Provista, including ... compounding pharmacy in California . He assumed ... "Jim is a great fit for Provista," says ...
Breaking Medicine Technology: